Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xilio Therapeutics (XLO) Prepaid Assets (2024 - 2025)

Xilio Therapeutics (XLO) has disclosed Prepaid Assets for 2 consecutive years, with $2.5 million as the latest value for Q4 2025.

  • Quarterly Prepaid Assets fell 49.5% to $2.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.5 million through Dec 2025, down 49.5% year-over-year, with the annual reading at $2.5 million for FY2025, 49.5% down from the prior year.
  • Prepaid Assets hit $2.5 million in Q4 2025 for Xilio Therapeutics, down from $2.8 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $5.2 million in Q1 2024 to a low of $2.0 million in Q3 2024.